INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a veterans affairs medical center

Journal of Managed Care Pharmacy

Volumn 17, Issue 2, 2011, Pages 133-142

  Baker, Jennifer W ^a   Pierce, Kristi L ^b   Ryals, Casey A ^c  

^a Anticoagulation and Traveling Veteran Clinics   (United States)

^b Pharmacy Practice Resident   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; AMBULATORY CARE; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; ELECTRONIC MEDICAL RECORD; FEMALE; GOAL ATTAINMENT; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNOWLEDGE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PUBLIC HOSPITAL; QUESTIONNAIRE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VETERAN;

EID: 79952603877     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2011.17.2.133     Document Type: Article

References (18)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl):160S-198S. Available at: http://chestjournal.chestpubs.org/content/133/6_suppl/160S.full.pdf+html. Accessed January 12, 2011.
2. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl):257S-298S. Available at: http://chestjournal.chestpubs.org/content/133/6_suppl/257S.full.pdf+html. Accessed January 12, 2011.
3. Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulation therapy. Haematologica. 2002;87(10):1081-86. Available at: http://www.haematologica.org/cgi/reprint/87/10/1081. Accessed January 12, 2011.
4. Taylor FC, Ramsay ME, Tan G, Gabbay J, Cohen H. Evaluation of patients' knowledge about anticoagulation treatment. Qual Health Care. 1994;3(2):79-85. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1055201/pdf/qualhc00011-0015.pdf. Accessed January 12, 2011.
5. Sipkoff M. Joint Commission sets anticoagulant therapy safety goal. Drug Topics. August 20, 2007. Available at: http://drugtopics.modernmedicine.com/drugtopics/Treatment+Areas/Joint-Commission-sets-anticoagulanttherapy-safety/ArticleStandard/Article/detail/450166. Accessed January 12, 2011.
6. The Joint Commission. Accreditation program: ambulatory care. National Patient Safety Goals. Effective January 1, 2011. Available at: http://www.jointcommission.org/assets/1/6/2011_NPSGs_AHC.pdf. Accessed January 12, 2011.
7. The Joint Commission. Accreditation program: hospital. National Patient Safety Goals. Effective January 1, 2011. Available at: http://www.jointcommission.org/assets/1/6/2011_NPSGs_HAP.pdf. Accessed January 12, 2011.
8. Estrada CA, Martin-Hryniewicz M, Peek BT, Collins C, Byrd JC. Literacy and numeracy skills and anticoagulation control. Am J Med Sci. 2004;328(2):88-93.
9. Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006;21(8):841-46. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1831580/pdf/jgi0021-0841.pdf. Accessed January 12, 2011.
10. Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients' warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37(1):34-39.
11. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med. 2004;164(18):2044-50. Available at: http://archinte.ama-assn.org/cgi/reprint/164/18/2044.pdf. Accessed January 12, 2011.
12. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632-36.
13. Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633-38.
14. Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40-59. Available at: http.://download.journals.elsevierhealth.com/pdfs/journals/1551-7411/PIIS1551741104000038.pdf. Accessed January 12, 2011.
15. Rosendaal F, Cannegieter S, Van Der Meer F, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236-39.
16. Hirschl M, Pluschnig U, Kundi M, Katzenschlager R. Oral anticoagulation in older patients with vascular or cardiovascular diseases. Aged over 70 years: same risk? Same benefit? Int Angiol. 2003;22(4):370-75.
17. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007;109(6):2419-23.
18. Hu A, Chow C, Dao D, Errett L, Keith M. Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement. J Cardiovasc Nurs. 2006:21(3);169-75.